about
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)Lessons of ALS imaging: Pitfalls and future directions - A critical reviewParamyotonia congenita and hyperkalemic periodic paralysis associated with a Met 1592 Val substitution in the skeletal muscle sodium channel alpha subunit--a large kindred with a novel phenotypeNEK1 variants confer susceptibility to amyotrophic lateral sclerosisReduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosisScreening for replication of genome-wide SNP associations in sporadic ALSAge of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease.The changing picture of amyotrophic lateral sclerosis: lessons from European registers.Genetic testing in ALS: A survey of current practices.Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data.Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristicsGenetic effects influencing risk for major depressive disorder in China and Europe.An exploratory spatial analysis of ALS incidence in Ireland over 17.5 years (1995-July 2013).Current pathways for epidemiological research in amyotrophic lateral sclerosis.Angiogenin levels and ANG genotypes: dysregulation in amyotrophic lateral sclerosisIncidence of amyotrophic lateral sclerosis in Europe.Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms.Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patternsThe path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costsAnalysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival studySymptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis.C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysisPitfalls in the diagnosis of motor neurone disease.The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues.Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.The epidemiology of ALS: a conspiracy of genes, environment and time.The effects of a home-based arm ergometry exercise programme on physical fitness, fatigue and activity in polio survivors: protocol for a randomised controlled trial.Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease.Cognitive impairment in amyotrophic lateral sclerosis.Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.Models of care for motor neuron disease: setting standards.Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.Functional Connectivity Changes in Resting-State EEG as Potential Biomarker for Amyotrophic Lateral Sclerosis.
P50
Q21261387-F2124C40-34AF-4852-9585-5A8CAA49FDA8Q24294908-5124891A-5D9A-44A2-B268-0E11FD5196B4Q26860864-8C75D2FD-4AB9-4E5C-9862-16FD5C02F139Q28236833-7D725CA4-CEE4-4B28-9B2D-DE62436ADEE1Q28277378-A27B7BC1-CB10-4A06-B7C5-98825F3F8D3BQ28943310-B5D2F378-F1AB-47CF-A8B4-1A15EE1B5F27Q28943381-D15AE863-6998-4D70-A225-6E0DF4C82EC9Q29417029-1F5ADC91-EF8F-43E6-AE38-88BB855D3AD8Q29417136-9671ABD8-CD71-48C2-866F-FF02DEC405CAQ30234433-E72388EE-0C79-41F3-8E85-2647A6201531Q30235329-0F4202C7-7DAA-4F4F-B310-8C68584D0138Q30236027-827003BE-829C-429C-A799-95F18EF061F4Q30866592-794EA831-39C9-44DE-93D6-A159E683C028Q31145143-525C3A64-1C71-48AE-AB06-526920A7BD0CQ33568729-808B78A3-C9D5-4FC7-BE61-61E67EBFC2D6Q33601878-7BD64E00-FFFC-47AD-8F6E-19AC167B0175Q33670384-088CB61E-30BE-4B78-89B2-86A6315BA647Q33697436-EF0F90AA-2203-4F35-8E6D-F5BA8B4C6990Q33750190-9B619EAA-016F-409A-A39A-ECFBBB1C00AFQ33774202-EFAA536A-EDC1-42E7-AB0D-19FDAEC7711DQ33796347-AE7DADB2-A200-4C4D-B046-CF51F04C013FQ33822826-EE691005-D32F-4481-91BB-1DF5C3F03A6BQ33825530-829B39C6-049E-48E6-88A1-71976F2C3637Q33870202-EFC43D05-255C-48EF-81EB-9CE540EBC6EBQ33932519-6C9E9D98-A605-48F8-A3B1-3CBAE9DD536EQ34063137-77745922-6761-4398-ADAB-1AC063CE515CQ34151797-E538D7EC-ACA5-481A-84CD-45EAF5BD77F3Q34165732-8E882849-5237-46EE-96C0-D3C284695255Q34235637-13285F9C-E79F-4E00-A6A5-3FB313A22EE3Q34340508-3437715B-D8BD-4FC6-858F-DBE1C89B372BQ34375695-FAF06FD2-7400-4F4B-8EE3-FAAEC00B2735Q34377698-25BB56FB-4C55-4DD6-A574-1F7490E9ACC9Q34509622-404E872A-9851-4C7C-BF5F-C81E27D34D9EQ34525563-11ABDBE0-857A-42B9-B21A-0DA2ADB1326AQ34583928-60AB4B01-EE4E-4F73-9E59-B67CD0F0492CQ35001476-1C4E35B0-F1FA-43D1-BC8A-79E189C33751Q35113111-C174301A-39DD-487C-BB9A-48B493F8D31DQ35476043-9ADC22D2-9804-4B8E-BA08-DFF7D0D15482Q35592875-B703D8F8-F6C0-4007-8B97-9DEDCEC98CF8Q35668800-35823698-F9A8-4BA9-AEA1-8C88324665F2
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Orla Hardiman
@ast
Orla Hardiman
@en
Orla Hardiman
@es
Orla Hardiman
@fr
Orla Hardiman
@nl
Orla Hardiman
@sl
type
label
Orla Hardiman
@ast
Orla Hardiman
@en
Orla Hardiman
@es
Orla Hardiman
@fr
Orla Hardiman
@nl
Orla Hardiman
@sl
prefLabel
Orla Hardiman
@ast
Orla Hardiman
@en
Orla Hardiman
@es
Orla Hardiman
@fr
Orla Hardiman
@nl
Orla Hardiman
@sl
P106
P1153
7007022710
P21
P31
P496
0000-0003-2610-1291